Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 20,655Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Dr. Reddy's Laboratories

02 1Supriya Lifescience

03 1Naprod Life Sciences

04 2AFT Pharmaceuticals

05 1ARTHUR GRP

06 1Accord healthcare

07 1Apotex Inc

08 1Aspiro Pharma

09 1Aurobindo Pharma Limited

10 1Baxter Healthcare Corporation

11 2Biological E

12 1Chia Tai Tianqing Pharmaceutical Group

13 1Etico Lifesciences

14 1Fresenius Kabi USA

15 1GENEYORK PHARMS

16 1Grupo Azevedos

17 1Lupin Ltd

18 1MERCK CANADA INC

19 2MSD INTL GMBH

20 1MSD(Pty) Ltd

21 1MSN Laboratories

22 2Medsurge Healthcare

23 7Merck & Co

24 1Navinta

25 1Piramal Enterprises Limited

26 1Polifarma

27 1Qilu Pharmaceutical

28 2Reach Pharmaceuticals

29 1Sagent Pharmaceuticals

30 1Sakar Healthcare

31 1Sandoz B2B

32 1Steriscience

33 1Tecnimede

34 1Teva Pharmaceutical Industries

35 1TherDose Pharma

36 2Viatris

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2020-12-09

Application Number : 211160

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Regulatory Info :

Registration Country : India

Fosaprepitant

Brand Name :

Dosage Form : Injection

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Supriya

03

arrow
PharmaVenue
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNaprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.

Regulatory Info :

Registration Country : India

Fosaprepitant Dimeglumine

Brand Name :

Dosage Form : Lyophilised Injection

Dosage Strength : 150MG/Vial

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Naprod Life Sciences

04

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2020-08-26

Application Number : 204025

Regulatory Info : DISCN

Registration Country : USA

blank

05

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 205020

Regulatory Info : DISCN

Registration Country : USA

blank

06

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2021-07-29

Application Number : 214616

Regulatory Info : RX

Registration Country : USA

blank

07

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2021-01-12

Application Number : 210625

Regulatory Info : RX

Registration Country : USA

blank

08

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 211860

Regulatory Info : RX

Registration Country : USA

blank

09

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 212309

Regulatory Info : RX

Registration Country : USA

blank

10

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2021-03-03

Application Number : 212143

Regulatory Info : RX

Registration Country : USA

blank

11

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name :

Dosage Form : Lyophilized Injection

Dosage Strength : 150MG/ML

Packaging : Single dose glass vial

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

12

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2016-06-09

Application Number : 206197

Regulatory Info : RX

Registration Country : USA

blank

13

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 210689

Regulatory Info : RX

Registration Country : USA

blank

14

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : EMEND

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2008-01-25

Application Number : 22023

Regulatory Info : DISCN

Registration Country : USA

blank

15

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : EMEND

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2010-11-12

Application Number : 22023

Regulatory Info : RX

Registration Country : USA

blank

16

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

fosaprepitant dimeglumine

Brand Name : IVEMEND

Dosage Form : POWDER FOR SOLUTION FOR INFUSION

Dosage Strength : 150 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

17

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

fosaprepitant dimeglumine

Brand Name : IVEMEND

Dosage Form : POWDER FOR SOLUTION FOR INFUSION

Dosage Strength : 115 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

18

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

fosaprepitant

Brand Name : Ivemend

Dosage Form : Fosaprepitant 150Mg 10 Ml 1 Units Parenteral Use

Dosage Strength : 1 vial EV 10 ml 150 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

19

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 209965

Regulatory Info : RX

Registration Country : USA

blank

20

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2020-08-20

Application Number : 212957

Regulatory Info : DISCN

Registration Country : USA

blank

21

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2023-05-16

Application Number : 214683

Regulatory Info : RX

Registration Country : USA

blank

22

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2020-09-08

Application Number : 213106

Regulatory Info : RX

Registration Country : USA

blank

23

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : UNKNOWN

Dosage Strength : UNKNOWN

Packaging :

Approval Date :

Application Number : 204845

Regulatory Info :

Registration Country : USA

blank

24

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2020-12-08

Application Number : 203939

Regulatory Info : DISCN

Registration Country : USA

blank

25

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOCINVEZ

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/50ML (EQ 3MG BASE/ML)

Packaging :

Approval Date : 2023-08-22

Application Number : 216686

Regulatory Info : RX

Registration Country : USA

blank

26

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 210064

Regulatory Info : RX

Registration Country : USA

blank

27

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 115MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 204015

Regulatory Info : DISCN

Registration Country : USA

blank

28

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 204015

Regulatory Info : RX

Registration Country : USA

blank

29

GENEYORK PHARMS

Country
PharmaVenue
Not Confirmed
arrow

GENEYORK PHARMS

Country
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 211624

Regulatory Info : DISCN

Registration Country : USA

blank

30

ARTHUR GRP

Country
PharmaVenue
Not Confirmed
arrow

ARTHUR GRP

Country
arrow
PharmaVenue
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2021-10-04

Application Number : 213199

Regulatory Info : DISCN

Registration Country : USA

blank